NCT07318337 2026-01-09
PCOS FAI CHC
Bangladesh Medical University
Phase NA Completed
Clinical Trials
12 trialsNCT03819140 2025-11-14
CCOUP
University of California, San Francisco
Phase 4 Completed
NCT06608186 2025-01-22
PPOS
Benha University
Phase 1/2 Completed
NCT04831151 2022-05-19
The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
Inonu University
Phase NA Unknown
NCT00640224 2017-11-17
Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study
University of Pittsburgh
Phase 4 Completed
NCT00714233 2015-05-15
Treatment of Adolescent Polycystic Ovary Syndrome (PCOS)
University of Rochester
Phase 3 Completed
NCT02027337 2014-11-21
Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants
Tyumen State Medical Academy
Phase 4 Unknown
NCT00442689 2014-06-06
Metabolic Syndrome in PCOS: Precursors and Interventions
Northwestern University
Phase NA Completed
NCT01603745 2012-05-22
Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome
Catholic University of the Sacred Heart
Phase 1 Unknown
NCT01581814 2012-04-20
Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome
Catholic University of the Sacred Heart
Phase 3 Completed
NCT01511822 2012-01-19
Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance
AGUNCO Obstetrics and Gynecology Centre
Phase 4 Completed
NCT01459445 2011-10-25
Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome
Iuliu Hatieganu University of Medicine and Pharmacy
Phase NA Unknown